Actively Recruiting
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
Led by Institut Bergonié · Updated on 2025-10-02
10000
Participants Needed
7
Research Sites
730 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease. In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling. Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
CONDITIONS
Official Title
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of solid malignant tumor or hematological malignancy
- Social security in compliance with French biomedical research law (Article L.1121-11 of French Public Health Code)
- Voluntarily signed and dated informed consent prior to any study procedure
You will not qualify if you...
- Individuals deprived of liberty or under guardianship
- Pregnant or breastfeeding women
- Previous enrollment in the present study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Centre Hospitalier de la Côte Basque
Bayonne, France, 64000
Actively Recruiting
2
Clinique Tivoli-Ducos
Bordeaux, France, 33000
Actively Recruiting
3
Institut Bergonie
Bordeaux, France, 33076
Actively Recruiting
4
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France, 33077
Actively Recruiting
5
Centre Hospitalier de Pau
Pau, France, 64000
Not Yet Recruiting
6
Clinique Marzet
Pau, France, 64000
Actively Recruiting
7
Centre Eugène Marquis
Rennes, France
Active, Not Recruiting
Research Team
A
Antoine ITALIANO, MD, PhD
CONTACT
S
Simone MATHOULIN-PELISSIER, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here